SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects

Clinical trial NCT05215808 · UNKNOWN

Trial details

NCT number: NCT05215808
Sponsor: Ribon Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-03-07
Primary completion: 2024-06-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.